FLEX - Does anybody have concerns that FLEX was a open-label study and hence might be harder to convince FDA of the validity of results? Is it usual for pivotal trials to be open-label, and if not was there any particular reason why FLEX was open-label.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.